Mouse MIP1b (Macrophage Inflammatory Protein 1 Beta) Sandwich ELISA Kit Ready-To-Use

Katalog-Nummer NB-22-63614-48

Size : 48T

Marke : Neo Biotech

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

  • Mouse MIP1b (Macrophage Inflammatory Protein 1 Beta) Sandwich ELISA Kit Ready-To-Use

General Info

Applications: ELISA
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Sensitivity: 4.3pg/mL
Detection Limit: 12.5-800pg/mL
Short Description: This MIP1b Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in mouse cell culture supernatant, serum and plasma (EDTA, citrate, heparin).
Storage Instruction: Store the unopened kit in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit.
Assay Time: 3 hrs

Information

Gene Symbol: Ccl4
Gene ID: 20303
Uniprot ID: CCL4_MOUSE
Immunogen Region: Ready-To-Use
Sample Type: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Description

Tissue Specificity
Post Translational Modifications
Function Monokine with inflammatory and chemokinetic properties.
Protein Name C-C Motif Chemokine 4
Immune Activation Protein 2
Act-2
Act2
Macrophage Inflammatory Protein 1-Beta
Mip-1-Beta
Protein H400
Sis-Gamma
Small-Inducible Cytokine A4
Database Links Reactome: R-MMU-380108
Reactome: -MMU-418594
Cellular Localisation Secreted
Alternative ELISA Names C-C Motif Chemokine 4 ELISA kit
Immune Activation Protein 2 ELISA kit
Act-2 ELISA kit
Act2 ELISA kit
Macrophage Inflammatory Protein 1-Beta ELISA kit
Mip-1-Beta ELISA kit
Protein H400 ELISA kit
Sis-Gamma ELISA kit
Small-Inducible Cytokine A4 ELISA kit
Ccl4 ELISA kit
Mip1b ELISA kit
Scya4 ELISA kit
output

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance